Budapest, Hungary

Zsuzsanna Tomoskozi

USPTO Granted Patents = 4 

Average Co-Inventor Count = 10.9

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Zsuzsanna Tomoskozi: Pioneering CXCR3 Receptor Antagonists

Introduction

Zsuzsanna Tomoskozi, an accomplished inventor based in Budapest, Hungary, has made significant contributions to the field of pharmaceutical sciences. With four patents to her name, she is recognized for her innovative research and development in the area of compounds targeting the CXCR3 receptor. Her work aims to address various diseases linked to abnormal CXCR3 chemokine activation.

Latest Patents

One of Zsuzsanna's latest inventions includes "Substituted B-amino acid derivatives as CXCR3 receptor antagonists." This patent describes compounds that are instrumental in the preventive and therapeutic treatment of diseases caused by abnormal CXCR3 chemokine activation. Additionally, the patent details a process for preparing these compounds, the pharmaceutical compositions that contain them, and novel intermediates used in their preparation.

Another recent patent of hers is "Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists," which similarly focuses on compounds that aid in treating diseases associated with abnormal CXCR3 activation. Like the previous work, it includes the methodologies for synthesizing the compounds, as well as pharmaceutical formulations utilizing them.

Career Highlights

Zsuzsanna has gained extensive experience through her roles at leading pharmaceutical companies, including Sanofi and Sanofi-Aventis. Her career has been marked by her dedication to innovating therapeutic solutions that advance healthcare.

Collaborations

Throughout her career, Zsuzsanna has collaborated with notable colleagues in the field, including Sandor Batori and Peter Aranyi. These collaborations have fostered a dynamic exchange of ideas, contributing to the advancement of their shared research goals.

Conclusion

Zsuzsanna Tomoskozi exemplifies the spirit of innovation through her groundbreaking work on CXCR3 receptor antagonists. Her patents underscore her commitment to developing new therapeutic avenues that hold promise for patients suffering from related diseases. As her career continues, she is poised to make even greater strides in the realm of pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…